UMIN ID: UMIN000000669
Registered date:01/09/2007
Neoadjuvant immunochemotherapy using intratumoral injection of dendritic cells for thoracic esophageal cancers
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Thoracic esophageal cancers |
Date of first enrollment | 2007/07/01 |
Target sample size | 10 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | intratumoral injection of dendritic cells on day 3 in the 1st course of neoadjuvant chemotherapy. |
Outcome(s)
Primary Outcome | Incidence of adverse event |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 80years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients with serious concomitant disease Patients with autoimmune disease |
Related Information
Primary Sponsor | Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Ministry of Education, Culture Sports, Science and Technology |
Secondary ID(s) |
Contact
public contact | |
Name | Hiroshi Miyata |
Address | Japan |
Telephone | |
hmiyata@gesurg.med.osaka-u.ac.jp | |
Affiliation | Graduate School of Medicine, Osaka University Department of Gastroenterological Surgery |
scientific contact | |
Name | Yuichiro Doki |
Address | 2-2, Yamadaoka, Suita, Osaka, Japan Japan |
Telephone | 06-6879-3251 |
Affiliation | Graduate School of Medicine, Osaka University Department of Gastroenterological Surgery |